Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study (Q83990373)
Jump to navigation
Jump to search
scientific article published on 28 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study |
scientific article published on 28 April 2011 |
Statements
Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study (English)
Richard Rokyta
Jitka Tesarova
Jan Belohlavek